Company intelligence / Profile preview

ArevaPharma

Georgetown, Indiana, United States

Ownership: Private
Development stage: Other

Overview

Areva Pharmaceuticals is a privately held specialty pharmaceutical company focused on the development, manufacturing, and marketing of generic injectable medications. The company specializes in providing high-quality, cost-effective alternatives for critical care, oncology, and other hospital-based therapeutic areas. Areva manages a diverse portfolio of FDA-approved products and maintains a robust supply chain to ensure the availability of essential medicines in the US market. Their business model emphasizes strategic partnerships and efficient regulatory pathways to bring complex generics to market.

Therapeutic areas: OtherCardiovascularNeurologyGastroenterologyOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on ArevaPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArevaPharma.

Explore the full profile